Freestone Capital Holdings’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-6,288
Closed -$286K 349
2013
Q3
$286K Buy
+6,288
New +$287K 0.05% 285

Other funds holding MRK

Freestone Capital Holdings's MRK Position: Q1 2026 in Review

Freestone Capital Holdings reduced its Merck (MRK) stake by 6.6% in Q1 2026, selling an estimated $662K and leaving 81,403 shares worth $9.79M. The position accounts for 0.3% of the portfolio, ranked #60.

Freestone Capital Holdings first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $13.6M in Q3 2021. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Freestone Capital Holdings held 81,403 shares of Merck worth $9.79M as of Q1 2026.
  • Freestone Capital Holdings sold 5,732 Merck shares in Q1 2026, an estimated $662K.
  • Merck made up 0.3% of Freestone Capital Holdings's portfolio in Q1 2026, its #60 holding.
  • Freestone Capital Holdings first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
  • Freestone Capital Holdings's Merck position peaked at $13.6M in Q3 2021.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.